Chinese Regulators OK Neusoft Medical’s Photon-Counting CT

Neusoft Medical Systems has earned China National Medical Products Administration approval for its NeuViz P10 photon-counting CT. The authorization is the Middle Kingdom’s first for a photon‑counting CT, and the world’s first wide‑body system equipped with an 8‑cm detector.

Photon-counting CT (PCCT) is considered a breakthrough in next‑generation imaging, according to the company. Unlike conventional CT scanners, which first convert X‑rays into light before generating digital images, the NeuViz P10 uses a cadmium zinc telluride (CZT) detector to capture and convert each X‑ray photon directly into a digital signal. This direct approach delivers images with far greater clarity, reduces radiation exposure for patients, and improves the ability to distinguish between different tissue types.

For patients, these advances mean clearer visualization of tiny blood vessels in the heart, earlier small tumor detection, more accurate identification of neurological conditions, and safer lung examinations with reduced radiation exposure. The system’s ultra-high resolution also helps doctors detect diseases at earlier stages, when treatment can be more effective and outcomes significantly improved.

To maximize clinical and research value, the NeuViz P10 integrates four innovation platforms: NeuPhoton Counting, Photon Supersonic, Photon Intelligence, and Photon Research. Together, these platforms deliver faster scans, safer imaging, intelligent workflow support, and expanded opportunities for clinical research, Neurosoft Medical bigwigs claim.

“The approval of NeuViz P10 is a milestone for China’s medical imaging industry and for global CT innovation,” Neusoft Medical Systems CEO Patrick Wu stated. “This technology empowers radiologists with clearer images at lower doses, giving patients earlier and more accurate answers while delivering maximum clinical value for public health.”

Neusoft Medical Systems develops medical imaging solutions and services. The company is dedicated to integrating AI technologies with medical imaging to deliver intelligent, efficient, precise, and reliable products and services. By the end of 2024, Neusoft Medical Systems had a presence in more than 120 countries and regions, serving over 14,000 customers, with a historical installed base exceeding 50,000 units.